uric acid has been researched along with Delayed Hypersensitivity in 6 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline was able to ameliorate this nephrotoxic condition as suggested by the change in levels of membrane bound ATPases, MDA and GSH." | 1.40 | Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline. ( Bhamre, P; Gandhi, H; Khakhariya, R; Rajput, SJ; Rathod, SP; Trivedi, J; Variya, B, 2014) |
| " Results suggest that very-low-calorie diets can be an effective and safe means of substantial weight reduction." | 1.27 | Safety and effectiveness of weight reduction using a very-low-calorie formulated food. ( Budell, W; Clements, M; Kreitzman, SN; Krissman, P; Nichols, D; Pedersen, M, 1984) |
| "Hyperuricaemia in Down's syndrome is unreleated to the activity of phosphoribosylamidotransfrease, which catalyses the activity of the first specific step on the purine biosynthetic pathway, and to the activity of hypoxanthine phosphoribosyltransferase and phosphoribosylpyrophosphate synthetase, abnormalities of which are known to be associated with hyperuricaemia." | 1.26 | Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome. ( Allsop, J; Newton, C; Perera, YS; Platts-Mills, TA; Watts, RW; Webster, AD, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khakhariya, R | 1 |
| Rathod, SP | 1 |
| Gandhi, H | 1 |
| Variya, B | 1 |
| Trivedi, J | 1 |
| Bhamre, P | 1 |
| Rajput, SJ | 1 |
| HELLER, H | 1 |
| Zare, F | 1 |
| Magnusson, M | 1 |
| Bergström, T | 1 |
| Brisslert, M | 1 |
| Josefsson, E | 1 |
| Karlsson, A | 1 |
| Tarkowski, A | 1 |
| Kreitzman, SN | 1 |
| Pedersen, M | 1 |
| Budell, W | 1 |
| Nichols, D | 1 |
| Krissman, P | 1 |
| Clements, M | 1 |
| Watts, RW | 1 |
| Perera, YS | 1 |
| Allsop, J | 1 |
| Newton, C | 1 |
| Platts-Mills, TA | 1 |
| Webster, AD | 1 |
| Glynn, LE | 1 |
6 other studies available for uric acid and Delayed Hypersensitivity
| Article | Year |
|---|---|
Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carboplatin; Creatin | 2014 |
TOXICITY OF DIURETICS.
Topics: Blood; Diuretics; Gastrointestinal Diseases; Gout; Hematologic Diseases; Humans; Hyperglycemia; Hype | 1965 |
Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis.
Topics: Animals; Arthritis, Experimental; Chemotaxis; Chemotaxis, Leukocyte; Disease Models, Animal; Down-Re | 2006 |
Safety and effectiveness of weight reduction using a very-low-calorie formulated food.
Topics: Blood Proteins; Body Weight; Cholesterol; Diet, Reducing; Electrolytes; Food, Formulated; Humans; Hy | 1984 |
Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
Topics: Adolescent; Adult; Amidophosphoribosyltransferase; Down Syndrome; Erythrocytes; Female; Humans; Hype | 1979 |
The chronicity of inflammation and its significance in rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Animals; Antibodies; Antigens; Arthritis, Rheumatoid; Autoimmune Diseases; C | 1968 |